Clotting disorders, particularly Antiphospholipid Syndrome (APS) and certain inherited thrombophilia’s, are established factors that can influence pregnancy outcomes and, in some cases, the ability to conceive. While most women with these conditions have successful pregnancies, the increased tendency for “sticky blood” can interfere with the delicate biological processes required for a healthy gestation. In the UK, healthcare professionals specialise in managing these risks through targeted treatments that support placental health and blood flow. Understanding the link between the circulatory system and reproductive health is a vital step in ensuring that patients with these disorders receive the appropriate level of obstetric and haematological support.
What We’ll Discuss in This Article
- The role of blood flow in successful embryo implantation
- How clotting disorders contribute to recurrent miscarriage
- The impact of microscopic clots on placental development
- Differences between inherited thrombophilia and APS in pregnancy
- Management strategies to improve live birth rates
- When to seek specialist fertility and haematology reviews
Clotting Disorders and the Challenge of Implantation
While the link between clotting disorders and miscarriage is well-documented, the impact on initial fertility the ability to get pregnant is more complex. For an embryo to implant successfully, the lining of the womb must have a robust and healthy blood supply. Some researchers suggest that an overactive clotting system may lead to microscopic blockages in the tiny vessels supplying the uterine lining, which could theoretically hinder the early stages of attachment. The NHS notes that while most women with clotting disorders do not have difficulty conceiving, those undergoing assisted reproduction like IVF may be screened for these conditions if they experience repeated implantation failure.
Recurrent Miscarriage and “Sticky Blood”
One of the primary ways clotting disorders manifest in reproductive health is through recurrent miscarriage, defined in the UK as the loss of three or more consecutive pregnancies. Antiphospholipid Syndrome (APS) is a leading treatable cause of this issue. The antibodies associated with APS can cause the blood to clot more easily and can also cause inflammation in the cells that form the early placenta. This dual action can disrupt the pregnancy in the first trimester. Because of this known association, UK clinical guidelines recommend testing for APS in any woman who has experienced recurrent early miscarriages or a single late-term pregnancy loss.
The Role of the Placenta and Blood Flow
As a pregnancy progresses, the placenta acts as the life-support system for the foetus, facilitating the exchange of oxygen and nutrients. Clotting disorders can pose a risk to this process by causing “placental insufficiency.” If microscopic clots form within the placental vessels, the flow of blood to the baby is restricted. This can lead to complications such as intrauterine growth restriction (IUGR), where the baby does not grow at the expected rate, or pre-eclampsia, a condition involving high blood pressure in the mother. NICE guidelines focus on the use of low-dose aspirin and heparin to prevent these placental clots and ensure the baby receives a consistent blood supply.
Inherited vs. Acquired Disorders in Pregnancy
The risk to a pregnancy varies depending on whether the clotting disorder is inherited (like Factor V Leiden) or acquired (like APS).
- Antiphospholipid Syndrome (APS): This condition carries the highest risk for pregnancy complications because the antibodies directly attack the placental tissues. Without treatment, the chances of a successful pregnancy are significantly lower.
- Inherited Thrombophilia’s: Conditions like Factor V Leiden or Protein C deficiency primarily increase the risk of the mother developing a deep vein thrombosis (DVT). While they can be associated with pregnancy loss, the link is often considered less direct than with APS, and many women with these genetic traits have uncomplicated pregnancies without intensive intervention.
Clinical Management and Success Rates
The management of clotting-related pregnancy issues in the UK has evolved to be highly effective. For women with APS or a history of clots, a combination of daily low-dose aspirin and daily heparin injections is the standard of care. This “dual therapy” addresses both the platelet activity and the clotting factors, significantly improving the chances of a healthy live birth. Treatment usually begins as soon as a pregnancy is confirmed or sometimes while trying to conceive and continues throughout the pregnancy and for six weeks after delivery. With this specialist management, most women with these conditions achieve successful outcomes.
When to Seek Specialist Advice
If you have a known clotting disorder and are planning a pregnancy, it is important to have a “pre-conception” consultation with your GP or a haematologist. They can review your medication and ensure you are on the safest possible regimen before you conceive. Similarly, if you have experienced recurrent miscarriages without a known cause, you should be referred to a specialist recurrent miscarriage clinic for investigations, which will include screening for APS and other thrombophilia’s. Early diagnosis and a coordinated care plan are the keys to managing the intersection of vascular and reproductive health.
Conclusion
Clotting disorders can cause miscarriages and influence pregnancy health by disrupting the blood supply to the womb and the placenta. While these conditions present challenges, they are highly manageable with modern medical treatments such as aspirin and heparin. By working closely with a multidisciplinary team of obstetricians and haematologists, most women with these disorders can navigate pregnancy safely and successfully. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can clotting disorders cause miscarriages or fertility problems?
Yes, they can lead to recurrent miscarriages and placental issues, though they are less commonly a direct cause of basic infertility (difficulty conceiving).
Is there a specific test for “sticky blood” and miscarriage?
In the UK, doctors test for Antiphospholipid Syndrome (APS) by looking for three specific antibodies in the blood on two separate occasions.
Do I need to take heparin if I only have one copy of Factor V Leiden?
Not always; your doctor will assess your personal and family history to decide if you need injections or just close monitoring during pregnancy.
Can aspirin alone prevent a miscarriage in APS?
For most women with a confirmed APS diagnosis, a combination of both aspirin and heparin is more effective than aspirin alone.
Will my baby inherit my clotting disorder?
If the disorder is genetic (like Factor V Leiden), there is a chance the baby will inherit the gene, but they may never experience any symptoms or complications.
Does a clotting disorder increase the risk of pre-eclampsia?
Yes, because clotting issues can affect the development of the placenta, which is a key factor in the onset of pre-eclampsia.
Is it safe to have IVF if I have a clotting disorder?
Yes, but your fertility clinic will work closely with a haematologist to manage the increased clot risk associated with the hormones used in IVF.
Authority Snapshot (E-E-A-T)
This article examines the relationship between clotting disorders and reproductive health in accordance with UK clinical standards. The content is reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine and acute care where the management of high-risk obstetric patients is a focus. All information provided is strictly aligned with the clinical guidelines and risk assessment pathways established by the NHS and NICE.
